Cardiac amyloidosis red flags: What all the cardiologist have to know

Area of Science:

• Cardiology
• Internal Medicine
• Genetics

Background:

• Cardiac amyloidosis is an increasingly recognized systemic disease.
• Early diagnosis is vital for effective management and improved patient outcomes.
• Systemic involvement with cardiac and extracardiac signs (red flags) should prompt suspicion.

Purpose of the Study:

• To highlight the importance of identifying red flags for early cardiac amyloidosis diagnosis.
• To emphasize the role of diagnostic tools in conjunction with clinical signs.
• To underscore the impact of timely diagnosis on treatment strategies and patient prognosis.

Main Methods:

• Review of clinical presentations and diagnostic modalities for cardiac amyloidosis.
• Identification of key cardiac and extracardiac red flags.
• Correlation of diagnostic findings with associated conditions like heart failure and neuropathy.

Main Results:

• Cardiac amyloidosis diagnosis relies on a combination of clinical suspicion, electrocardiography, and advanced imaging (echocardiography, cardiac MRI, scintigraphy).
• Extracardiac manifestations such as orthopedic issues, peripheral neuropathy, and plasma cell dyscrasia are critical indicators.
• Associated conditions include valvular disorders, heart failure, and cardiomyopathy.

Conclusions:

• Recognizing red flags is paramount for the early diagnosis of cardiac amyloidosis.
• Integrated diagnostic approaches improve detection rates.
• Prompt diagnosis enables targeted therapies, including newly approved drugs for transthyretin amyloidosis, significantly altering patient outcomes.